1Thomsen HS. Nephrogenic Systemic Fibrosis: a Serious Late Adverse Reaction to Gadodiamide [J]. Eur Radiol, 2006, 16 ( 12 ) : 2619-2621.
2Cowper SE, Robin HS, Steinberg SM, et al. Scleromyxoedema-like Cutaneous Diseases in Renal-dialysis Patients[J]. Lancet, 2000, 356(9234) : 1000-1001.
3Ting WW, Stone MS, Madison KC, et al. Nephrogenic Fibrosing Dermopathy With Systemic Involvement[J]. Arch Dermatol,2003,139(7):903-906.
4Cowper SE,Bucala R, LeBoit PE. Nephrogenic Fibrosing Dermopathy/nephrogenic Systemic Fibrosis-setting the Record Straight [J]. Semin Arthritis Rheum,2006,35(4) :208-210.
5Cowper SE. The International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR)[M]. Official Site of the Nephrogenie Fibrosing Dermopathy (NFD/NSF) Registry,2007.1-6.
6DeHoratius DM, Cowper SE. Nephrogenic Systemic Fibrosis: an Emerging Threat Among Renal Patients[J]. Semin Dial, 2006, 19 (3) : 191-194.
7Jain SM, Wesson S, Hassanein A, et al. Nephrogenic Fibrosing Dermopathy in Pediatric Patients[J]. Pediatr Nephrol, 2004, 19 (4) :467-470.
8FDA. Development of Serious and Sometimes Fatal Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy [J]. J Radiol Nursi, 2007,26 ( 1 ): 29-30.
9Deo A, Fogel M, Cowper SE. Nephrogenie Systemic Fibrosis: A Population Study Examining the Relationship of Disease Development to Gadolinium Exposure [J]. Clin J Am Soc Nephrol, 2007; CJN.
10Kuo PH, Kanal E, Abu Alfa AK,Cowper SE. Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis[J]. Radiology, 2007,242(3) :647-649.
